A glowing clue: light sensor may spot kidney damage in newborns

NCT ID NCT07743099

First seen Aug 03, 2026 · Last updated Aug 14, 2026 · Updated 2 times

Summary

This study tests whether a non-invasive light-based monitor, called near-infrared spectroscopy (NIRS), can detect kidney injury early in newborns with hypoxic-ischemic encephalopathy (HIE) who are undergoing cooling therapy. The monitor measures oxygen levels in the kidneys and brain continuously for 72 hours. Researchers will compare these readings between newborns who develop acute kidney injury and those who do not, to see if NIRS can serve as an early warning sign.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Continuous cerebral and bilateral renal near-infrared spectroscopy (NIRS) monitoring
What this could lead to
If successful, this could enable earlier, non-invasive detection of kidney injury in newborns with HIE, potentially improving outcomes.
What could go wrong
This is a small observational study, so results may not be conclusive. NIRS readings can be affected by various factors, and the technique may not reliably distinguish all cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kayseri City Hospital

    Kayseri, Kayseri, 38090, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.